A new health-related quality of life instrument for leukemia: will it be widely adopted soon?
Background: The rapid escalation in the treatment costs of cancer, as well as modest survival gains of the treatment, drive an emerging need to determine the value of cancer therapy from the perspectives of stakeholders such as patients, payers, There is an increasing role for health-related quality...
Main Authors: | Junhua Yu, Joanna Cheung |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2013-06-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | http://www.drugsincontext.com/a-new-health-related-quality-of-life-instrument-for-leukemia-will-it-be-widely-adopted-soon/ |
Similar Items
-
Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis
by: Amany El Zeiny, et al.
Published: (2024-01-01) -
PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01) -
Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
by: N. V. Miga, et al.
Published: (2022-11-01) -
A Structured Review of Generic and Specific Instruments for Measuring the Subjectively Assessed Quality of Life of Seniors
by: Monika Kacmarova, et al.
Published: (2015-12-01) -
Handbook of instruments and instrumentation
Published: (1977)